Application and research progress of synthetic lethality in the development of anticancer therapeutic drugs

Abstract excerpt

With the tremendous success of the PARP inhibitor olaparib in clinical practice, synthetic lethality has become an important field for the discovery and development of anticancer drugs. More and more synthetic lethality targets have been discovered with the rapid development of biotechnology in recent years. Currently, many drug candidates that were designed and developed on the basis of the concept of synthetic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to CRISPR and Genetic Engineering
• Share to PARP inhibition in cancer therapy
• Share to Toxin Mechanisms and Immunotoxins